SILO - Psyched: Biden Approves Psychedelics Trials RFK Australia's First Legal Dedicated Clinic & More | Benzinga
President Biden Approves Psychedelics Clinical Trials For Active Military Members
President Biden signed into law the 2024 National Defense Authorization Act (NDAA), large-scale legislation that also contains a mandate to fund clinical trials with psychedelics for active service members.
The decision was announced on Friday, Dec. 22, a little over a week after receiving the bill’s final version that was designed and approved in a bicameral move in Congress. Keep reading HERE.
Psychedelics Legalization & 2024 Election: Robert F. Kennedy Jr. Confirms Support In New Interview
Robert F. Kennedy Jr. shared his views and standpoint on psychedelics as a mental health treatment during a recent podcast interview.
The news comes at the same time as President Biden’s imminent call on whether to pass a large-scale defense bill that would fund studies with psychedelics on active duty service members.
The independent presidential candidate said an ayahuasca experience helped his son process the death of his mother, Kennedy's ex-wife Mary Richardson Kennedy, which influenced his own views on the topic. Read more HERE.
Incannex Healthcare To Open First Psychedelic-Assisted Therapy Clinic In Australia
Melbourne will soon open Clarion Clinics’ first exclusively dedicated facility to provide psychedelic-assisted therapies legalized in Australia.
The subsidiary to biotech Incannex Healthcare (NASDAQ: IXHL) received the required Human Research Ethics Committee (HREC) endorsement for the administration of MDMA and psilocybin therapies for PTSD and Treatment-Resistant Depression (TRD) respectively.
Reportedly "the only dedicated psychedelic-assisted therapy clinic in Australia” with a team comprised of renowned researchers, psychologists and psychiatrists, Clarion Clinics announced its intentions to open more clinics across the country and internationally. Learn more HERE.
The Milestone Round
-
Awakn Life Sciences (OTCMKTS: AWKNF) entered into a global licensing agreement for a ketamine sublingual delivery formulation.
-
Do psychedelic treatments always require psychotherapy? Well, we need to look 'beyond reductionism'.
-
Inebriation remedy and breakthrough MS treatment: Meet FSD Pharma (NASDAQ: HUGE).
-
Mississippi cannabis crisis, PA's decriminalization bill, kratom discussed in Congress and more.
-
Santa's secret psychedelic origin: Forget coke, Christmas is all about magic mushrooms.
-
Psychedelic cinema: 10 trippy holiday movies that warp reality
See Also: Last Week's Edition Of 'Psyched'
Kaleidoscope Corner
-
Filament Health (OTCMKTS: FLHLF) terminated its proposed business combination with Jupiter Acquisition.